TriSalus director converts preferred into common stock
TriSalus Life Sciences director David J. Matlin converted preferred stock into common shares under a company offer.
Rhea-AI Filing Summary
TriSalus Life Sciences director David J. Matlin converted preferred stock into common shares under a company offer. On July 31, 2025, all 100,000 shares of Series A Preferred Stock held by Matlin were converted into 330,000 shares of common stock.
The conversion followed an exchange offer allowing all preferred holders to receive common shares equal to the liquidation preference of $10.00 per preferred share plus accrued and unpaid dividends through August 10, 2027, divided by a $4.00 conversion price per share. After the conversion, Matlin directly owned 1,271,944 common shares and no remaining preferred shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
100,000 shares exercised/converted
Exercise
2 txns
Insider
MATLIN DAVID J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series A Preferred Stock | 100,000 | $0.00 | $0.00 |
| Conversion | Common Stock | 330,000 | $0.00 | $0.00 |
Holdings After Transaction:
Series A Preferred Stock — 0 contracts (Direct);
Common Stock — 1,271,944 shares (Direct)
Footnotes (3)
- F1. Represents shares received upon conversion of the Series A Preferred Stock (the "Preferred Stock") reported in Table II.
- F2. Represents conversion price pursuant to an offer (the "Offer") the Company commenced on June 23, 2025, under which all holders of Preferred Stock could exchange their shares of Preferred Stock for Common Stock equal to the sum of the liquidation preference per share price of $10.00 and all accrued and unpaid dividends per share outstanding through August 10, 2027, divided by a $4.00 conversion price per share.
- F3. On July 31, 2025, all 100,000 shares of Preferred Stock held by the Reporting Person were converted into 330,000 shares of Common Stock pursuant to the Offer.
Key Figures
Preferred shares converted: 100,000 shares
Common shares received: 330,000 shares
Conversion price: $4.00 per share
+3 more
6 metrics
Preferred shares converted
100,000 shares
Series A Preferred Stock converted on July 31, 2025
Common shares received
330,000 shares
Common Stock issued upon preferred conversion
Conversion price
$4.00 per share
Price used to calculate common shares in the offer
Liquidation preference
$10.00 per preferred share
Amount included in exchange offer calculation
Common shares after transaction
1,271,944 shares
Matlin’s direct common stock holdings following conversion
Preferred shares remaining
0 shares
All 100,000 Series A Preferred converted under the offer
Key Terms
Series A Preferred Stock, liquidation preference, accrued and unpaid dividends, conversion price, +1 more
5 terms
Series A Preferred Stock financial
"Represents shares received upon conversion of the Series A Preferred Stock"
Series A preferred stock is a type of ownership share in a company that gives investors certain advantages, such as priority in receiving profits or getting their money back if the company is sold or goes bankrupt. It is often issued during early funding stages to attract investors by offering more security than common shares. This stock matters to investors because it provides a safer way to invest while still holding potential for future gains.
liquidation preference financial
"equal to the sum of the liquidation preference per share price of $10.00"
A liquidation preference is a rule that determines who gets paid first and how much they receive when a company is sold, goes bankrupt, or distributes its assets. It gives certain investors a priority claim—often returning their original investment plus any agreed multiple—before other owners receive money, which shapes how much common shareholders and founders ultimately get; think of it as a front-of-the-line pass that affects payout order and investor returns.
accrued and unpaid dividends financial
"and all accrued and unpaid dividends per share outstanding through August 10, 2027"
Accrued and unpaid dividends are dividend payments that a company has declared or owes to shareholders but has not yet actually paid out. For investors this matters because it represents cash they expect to receive—like a paycheck that’s been earned but not yet issued—and signals the company’s payment priorities and short-term cash health, which can affect shareholder returns and claims in cases like restructuring.
conversion price financial
"divided by a $4.00 conversion price per share"
The conversion price is the fixed price at which a convertible security, like a bond or preferred stock, can be exchanged for shares of common stock. It acts like a set rate that determines how many shares an investor can receive if they choose to convert their investment. This helps investors understand the value and potential benefits of converting their securities into company shares.
Conversion of derivative security financial
"transaction_code_description: Conversion of derivative security"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TriSalus Life Sciences (TLSI) disclose for David J. Matlin?
TriSalus Life Sciences disclosed that director David J. Matlin converted 100,000 shares of Series A Preferred Stock into 330,000 shares of common stock. This followed a company offer allowing all preferred holders to exchange their shares on specified terms.
What was the conversion price used in the TriSalus (TLSI) preferred stock exchange offer?
The exchange offer used a $4.00 per share conversion price. Common shares received were based on the sum of the $10.00 liquidation preference per preferred share plus accrued and unpaid dividends through August 10, 2027, divided by this $4.00 price.
What was the nature of the TriSalus (TLSI) insider transaction reported on July 31, 2025?
The transaction was a conversion of a derivative security, not an open-market trade. Series A Preferred Stock was converted into common stock pursuant to an exchange offer, with terms tied to liquidation preference, accrued dividends, and a $4.00 conversion price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
